Clinical Trial Detail

NCT ID NCT02674763
Title Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ImmunoGen, Inc.
Indications

acute myeloid leukemia

Therapies

IMGN779

Age Groups: senior adult

No variant requirements are available.